REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a leader in genomic diagnostics for infectious diseases, announced today that the Karius Test® has been granted designation as a Breakthrough ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A pivotal multi-center study published in Clinical Infectious Diseases demonstrates the effectiveness of the Karius Test®, a blood test based on metagenomics ...
Please provide your email address to receive an email when new articles are posted on . The manufacturer of the Karius Test is seeking to market it for diagnosing lung infections in immunocompromised ...
The new partnership between Capstone Health Alliance and Karius provides more patients with access to the innovative the Karius Test® technology and helps improve the diagnosis of infections REDWOOD ...
REDWOOD CITY, Calif., Aug. 3, 2020 /PRNewswire/ -- Karius, the world leader in liquid biopsy for infectious diseases, announced today active enrollment in a multicenter, prospective study that will ...
Karius, a leader in infectious disease diagnostics, will collaborate with eGenesis, a pioneer in xenotransplantation, to expand the Karius microbial cell-free DNA sequencing platform to include ...
REDWOOD CITY, Calif., Oct. 6, 2020 /PRNewswire/ -- Karius, the world leader in liquid biopsy for infectious diseases, announced Alec Ford as the company's new Chief Executive Officer (CEO). Ford most ...
US-based life science company Karius has secured $100m in Series C funding, which was co-led by Khosla Ventures, 5AM Ventures, and Gilde Healthcare. New investors Seventure Partners joined existing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company's test taps a simple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results